Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
HERON THERAPEUTICS, INC.
Provisional
San Diego, CA · united states
1 recall flag(s)
FDA Flags (1)
Class III Recall
Aug 2022
HERON THERAPEUTICS, INC.
Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit,
Classification: Class III
HERON THERAPEUTICS, INC. | MedicineWatch US